Soligenix, Inc. (SNGX) Financials

SNGX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 10.5 million 3.9 million
March 31, 2026 6.9 million 3.8 million
Dec. 31, 2025 9.2 million 3.9 million
Sept. 30, 2025 11.3 million 3.7 million

SNGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -1.7 million ?
March 31, 2026 -2.4 million 121208
Dec. 31, 2025 -2.7 million 320125
Sept. 30, 2025 -2.9 million 104346

SNGX Net Income

No data available :(

SNGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 9.8 million - 302589
March 31, 2026 6.0 million - 330660
Dec. 31, 2025 7.9 million - 358144
Sept. 30, 2025 10.5 million - 385054

SNGX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 16.0 million
March 31, 2026 10.2 million
Dec. 31, 2025 10.1 million
Sept. 30, 2025 4.3 million

SNGX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 974091 1.1 million -
March 31, 2026 3 1.8 million 1.1 million -
Dec. 31, 2025 3925 2.3 million 1.2 million -
Sept. 30, 2025 608 1.6 million 996604 -

SNGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 1098
Dec. 31, 2025 - 1000
Sept. 30, 2025 - -

SNGX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SNGX

Price: $0.40

52 week price:
0.28
6.23

Payout Ratio Range:
-171.93%
-13.33%

Earnings Per Share: -1.47 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 16498

Ebitda: -951647

Market Capitalization: 8.5 million

Links: